Market Cap (In USD)
441.97 Million
Revenue (In USD)
41.28 Million
Net Income (In USD)
-37.92 Million
Avg. Volume
429.97 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3.165-5.545
- PE
- -
- EPS
- -
- Beta Value
- 1.16
- ISIN
- US57777K1060
- CUSIP
- 57777K106
- CIK
- 1287098
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Maher Masoud
- Employee Count
- -
- Website
- https://maxcyte.com
- Ipo Date
- 2021-07-30
- Details
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.
More Stocks
-
SHIVAMILLSShiva Mills Limited
SHIVAMILLS
-
ITOXIIOT-OXYS, Inc.
ITOX
-
ASFT
-
ENVIEnvipco Holding N.V.
ENVI
-
ADINATHAdinath Textiles Limited
ADINATH
-
ZTMUFZimtu Capital Corp.
ZTMUF
-
EACOEACO Corporation
EACO
-
NCH2